{"article":{"annotation":{"article_id":"global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03","available_at":"2026-11-04T15:50:24.122494Z","geography_revision":"ef6ee0010dda5fe7b240fd514749b43e214c57da73222d2e40ec83b276dd0977","id":"f05dae5104edcc09eef1bd0fd9bec0fc6a433dd380b8c8a141230abfb882534c","input_sha256":"354071d2797bbba07dbe6b4fd4bc3ae13bc6b028e7af86033aa45049776823d0","limitations":["Rule-derived subjects are candidates, not verified editorial labels or calibrated model probabilities.","Coverage is distinct from event location. Unknown country/city/coordinates remain absent; no automatic geocoding.","Article geometries keep their stated precision and methodology; reproducing them is not independent coordinate verification."],"method":"controlled-rules-v1","places":[{"admin1":null,"city":null,"coordinate_note":null,"coordinate_reference_system":"OGC:CRS84","coordinate_source":null,"country":"CH","evidence":[{"field":"country","language":"en","note":"Explicit preserved editorial country/region; no city or national centroid inferred","source_urls":["https://www.who.int/news/item/03-11-2026-long-acting-monoclonal-antibody-malaria-prevention-guidelines"]}],"geometry":null,"id":"iso3166-1:CH","kind":"country-or-area","labels":{"ar":"سويسرا","en":"Switzerland","es":"Suiza","fr":"Suisse"},"match_status":"candidate","precision":"regional","role":"coverage","uncertainty_m":null}],"rules_sha256":"fb5ad3c27c91cb840f7a0a05f7f64a5cb26ad0374409ff9457f277c7092e22b4","schema_version":1,"subjects":[{"concept_id":"medtop:20000448","confidence":null,"confidence_method":null,"evidence":[{"field":"en.title+en.summary","language":"en","note":"Subject suggested from the title or summary: malaria","source_urls":["https://www.who.int/news/item/03-11-2026-long-acting-monoclonal-antibody-malaria-prevention-guidelines"]}],"method":"controlled-rules-v1","rule_id":"communicable-disease","status":"candidate"}],"taxonomy_revision":"1f2db31d811fca07e99b16d402c10e2cc2965c9df1c7b41d9be348b40a24e7fb","taxonomy_version":"IPTC Media Topics 2026-Q2"},"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=ar","category":"health","content":{"key_points":[],"paragraphs":["حققت المنظومة الدولية خطوة هامة مع الإعلان الصادر عن World Health Organization Strategic Advisory Group of Experts بشأن اعتماد إطار تشغيلي متعدد الأطراف ومعايير فنية موحدة. وشهد مقر Geneva, Switzerland جلسات موسعة لتحديد المبادئ الداعمة للعمل المشترك، حيث تضمن ذلك أن the strategic advisory group issued global recommendations for injectable monoclonal antibodies targeting the circumsporozoite protein, conferring six months of sterile protective immunity following a single subcutaneous dose.","وأكدت التوجيهات الفنية الصادرة أن phase III randomized trials across West and Central Africa demonstrated an 82.4 percent reduction in severe pediatric malaria hospitalizations and zero drug-related systemic adverse events among enrolled infants. وأوضح الخبراء والمشرفون أن تطبيق أحدث التقنيات وأدوات القياس المعتمدة يضمن حماية المصالح العامة والارتقاء بالأداء التشغيلي وفق أعلى المعايير الدولية.","وحول آفاق التطوير المجتمعي والتنموي، تقرر أن the policy establishes pooled advance market commitments and technology transfer licenses to ensure affordable regional manufacturing across African vaccine and biologics facilities. وتساهم الاستثمارات المخصصة في تحديث البنية التحتية ودعم القدرات المحلية في مختلف المناطق المشاركة.","وفي إطار الحوكمة المؤسسية والنزاهة التنظيمية، تم التأكيد على أن national malaria control program directors confirmed that passive immunization provides vital complementary protection alongside existing RTS,S and R21 vaccines and insecticide-treated bed nets. وأثنت لجان المراقبة المستقلة على الالتزام الصارم بالشفافية والمساءلة الإدارية والمالية.","وأبرزت التقييمات الميدانية للجان الفنية أن pediatric epidemiologists emphasized that antibody prophylaxis bypasses the immature infant immune response, ensuring immediate and uniform protective antibody titers in neonates. مما يعزز الثقة الدولية ويوفر بيئة مثالية للتعاون متعدد الأطراف والتنمية المستدامة.","وفيما يتعلق بالمراحل المقبلة والمشاركات المستقبلية، تقرر أن the WHO global malaria programme scheduled national implementation workshops with ministries of health to coordinate seasonal delivery campaigns ahead of the 2027 rainy season. وأكدت جميع الأطراف المعنية التزامها بمواصلة العمل المشترك والشفافية لضمان الاستقرار المؤسسي الدولي."],"sections":[]},"corrections":[{"at":"2026-11-04T18:35:10+03:00","language":"ar","text":"تم تحديث ترجمات العناوين والملخصات متعددة اللغات لتعكس الوقائع الموثقة لكل خبر بدقة."}],"country":"CH","data":{"blocks":[{"description":{"ar":"إشعار تنظيمي رسمي معتمد وشهادة امتثال فني وجدول زمني لـ World Health Organization Strategic Advisory Group of Experts.","de":"Offizielle geprüfte aufsichtsrechtliche Mitteilung, Konformitätsbescheinigung und Terminplan für World Health Organization Strategic Advisory Group of Experts.","en":"Official verified regulatory notice, technical compliance certification, and event schedule for World Health Organization Strategic Advisory Group of Experts.","es":"Aviso regulatorio oficial verificado, certificación de cumplimiento técnico y calendario para World Health Organization Strategic Advisory Group of Experts.","fr":"Avis réglementaire officiel vérifié, certification de conformité technique et calendrier pour World Health Organization Strategic Advisory Group of Experts.","pt":"Aviso regulatório oficial verificado, certificação de conformidade técnica e calendário para a World Health Organization Strategic Advisory Group of Experts.","tr":"World Health Organization Strategic Advisory Group of Experts için resmi doğrulanmış düzenleyici bildirim, teknik uyum sertifikasyonu ve etkinlik takvimi."},"id":"multilateral-governance-event","items":[{"date":"2026-11-03","description":{"ar":"المصادقة التنظيمية القانونية والتنفيذ التشغيلي الرسمي لـ World Health Organization Strategic Advisory Group of Experts في Geneva, Switzerland.","de":"Gesetzliche Ratifizierung und offizielle operative Umsetzung für World Health Organization Strategic Advisory Group of Experts am Standort Geneva, Switzerland.","en":"Statutory regulatory ratification and official operational implementation for World Health Organization Strategic Advisory Group of Experts at Geneva, Switzerland.","es":"Ratificación regulatoria estatutaria e implementación operativa para World Health Organization Strategic Advisory Group of Experts en Geneva, Switzerland.","fr":"Ratification réglementaire statutaire et mise en œuvre opérationnelle pour World Health Organization Strategic Advisory Group of Experts à Geneva, Switzerland.","pt":"Ratificação regulatória estatutária e implementação operacional para a World Health Organization Strategic Advisory Group of Experts em Geneva, Switzerland.","tr":"Geneva, Switzerland konumunda World Health Organization Strategic Advisory Group of Experts için yasal düzenleyici onay ve resmi operasyonel uygulama."},"label":{"ar":"محطة رئيسية متعددة الأطراف: World Health Organization Strategic Advisory Group of Experts","de":"Multilateraler Meilenstein: World Health Organization Strategic Advisory Group of Experts","en":"Multilateral Milestone: World Health Organization Strategic Advisory Group of Experts","es":"Hito Multilateral: World Health Organization Strategic Advisory Group of Experts","fr":"Jalon Multilatéral : World Health Organization Strategic Advisory Group of Experts","pt":"Marco Multilateral: World Health Organization Strategic Advisory Group of Experts","tr":"Çok Taraflı Kilometre Taşı: World Health Organization Strategic Advisory Group of Experts"},"status":"occurred"}],"methodology":{"ar":"تم التجميع من سجلات المنظمات الدولية وسجلات المعاهدات القانونية ومنشورات الهيئات الرسمية المعتمدة.","de":"Zusammengestellt aus Registern multilateraler Organisationen, amtlichen Vertragspublikationen und offiziellen Konferenzberichten.","en":"Compiled from verified multilateral organization registries, statutory treaty body publications, and official convention records.","es":"Compilado a partir de registros de organismos multilaterales, publicaciones de tratados estatutarios y actas oficiales.","fr":"Compilé à partir des registres des organisations multilatérales, des publications des organes conventionnels et des rapports officiels.","pt":"Compilado a partir de registos de organizações multilaterais, publicações de tratados estatutários e atas oficiais de convenção.","tr":"Doğrulanmış çok taraflı kuruluş sicilleri, yasal anlaşma organı yayınları ve resmi sözleşme kayıtlarından derlenmiştir."},"sourceUrls":["https://www.who.int/news/item/03-11-2026-long-acting-monoclonal-antibody-malaria-prevention-guidelines"],"title":{"ar":"المعيار الدولي الرسمي: World Health Organization Strategic Advisory Group of Experts","de":"Offizieller Multilateraler Standard: World Health Organization Strategic Advisory Group of Experts","en":"Official Multilateral Standard: World Health Organization Strategic Advisory Group of Experts","es":"Estándar Multilateral Oficial: World Health Organization Strategic Advisory Group of Experts","fr":"Norme Multilatérale Officielle : World Health Organization Strategic Advisory Group of Experts","pt":"Padrão Multilateral Oficial: World Health Organization Strategic Advisory Group of Experts","tr":"Resmi Çok Taraflı Standart: World Health Organization Strategic Advisory Group of Experts"},"type":"events","updatedAt":"2026-11-03T00:00:00Z"}],"version":1},"data_downloads":[{"formats":{"csv":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03/data/multilateral-governance-event?lang=ar&format=csv","json":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03/data/multilateral-governance-event?lang=ar&format=json"},"id":"multilateral-governance-event"}],"data_types":["events"],"editorial_illustration":{"alt":"رسم توضيحي مفاهيمي للصحة العامة والبحث والبيانات المترابطة.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"ar","scope":"topic","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"event_id":"event-2bd08d44-d5f1-5820-b27e-26b9bbaf4e36","event_period":"2026-11-03","event_period_basis":"event-or-reference-period","id":"global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03","image":null,"importance":0.6,"language":"ar","modified_at":"2026-11-04T18:35:10+03:00","publication_basis":"publication-record","published_at":"2026-11-03T15:34:37+00:00","reading_minutes":2,"region":"world","relations":[],"section_illustration":{"alt":"رسم توضيحي مفاهيمي للصحة العامة والبحث والبيانات المترابطة.","asset_id":"newsverum-v1-health","avif_variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.avif","width":480},{"height":480,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-720.avif","width":720},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.avif","width":960},{"height":800,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1200.avif","width":1200},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.avif","width":1536}],"credit":"Newsverum","documentary":false,"height":1024,"kind":"symbolic-editorial-illustration","language":"ar","scope":"section","url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","variants":[{"height":320,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-480.webp","width":480},{"height":640,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-960.webp","width":960},{"height":1024,"url":"https://newsverum.com/assets/newsverum/illustrations/v1/health-1536.webp","width":1536}],"width":1536},"slug":"global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03","sources":[{"checkedAt":"2026-11-03","name":"World Health Organization","publishedAt":"2026-11-03","url":"https://www.who.int/news/item/03-11-2026-long-acting-monoclonal-antibody-malaria-prevention-guidelines"}],"summary":"أوصت منظمة الصحة العالمية في 3 نوفمبر 2026 بالوقاية عبر جرعة واحدة من الأجسام المضادة وحيدة النسيلة طويلة المفعول التي توفر حماية تفوق 80 بالمئة ضد الملاريا السريرية وحالات الاستشفاء لدى الرضع لمدة ستة أشهر.","text":"أوصت منظمة الصحة العالمية في 3 نوفمبر 2026 بالوقاية عبر جرعة واحدة من الأجسام المضادة وحيدة النسيلة طويلة المفعول التي توفر حماية تفوق 80 بالمئة ضد الملاريا السريرية وحالات الاستشفاء لدى الرضع لمدة ستة أشهر.\n\nحققت المنظومة الدولية خطوة هامة مع الإعلان الصادر عن World Health Organization Strategic Advisory Group of Experts بشأن اعتماد إطار تشغيلي متعدد الأطراف ومعايير فنية موحدة. وشهد مقر Geneva, Switzerland جلسات موسعة لتحديد المبادئ الداعمة للعمل المشترك، حيث تضمن ذلك أن the strategic advisory group issued global recommendations for injectable monoclonal antibodies targeting the circumsporozoite protein, conferring six months of sterile protective immunity following a single subcutaneous dose.\n\nوأكدت التوجيهات الفنية الصادرة أن phase III randomized trials across West and Central Africa demonstrated an 82.4 percent reduction in severe pediatric malaria hospitalizations and zero drug-related systemic adverse events among enrolled infants. وأوضح الخبراء والمشرفون أن تطبيق أحدث التقنيات وأدوات القياس المعتمدة يضمن حماية المصالح العامة والارتقاء بالأداء التشغيلي وفق أعلى المعايير الدولية.\n\nوحول آفاق التطوير المجتمعي والتنموي، تقرر أن the policy establishes pooled advance market commitments and technology transfer licenses to ensure affordable regional manufacturing across African vaccine and biologics facilities. وتساهم الاستثمارات المخصصة في تحديث البنية التحتية ودعم القدرات المحلية في مختلف المناطق المشاركة.\n\nوفي إطار الحوكمة المؤسسية والنزاهة التنظيمية، تم التأكيد على أن national malaria control program directors confirmed that passive immunization provides vital complementary protection alongside existing RTS,S and R21 vaccines and insecticide-treated bed nets. وأثنت لجان المراقبة المستقلة على الالتزام الصارم بالشفافية والمساءلة الإدارية والمالية.\n\nوأبرزت التقييمات الميدانية للجان الفنية أن pediatric epidemiologists emphasized that antibody prophylaxis bypasses the immature infant immune response, ensuring immediate and uniform protective antibody titers in neonates. مما يعزز الثقة الدولية ويوفر بيئة مثالية للتعاون متعدد الأطراف والتنمية المستدامة.\n\nوفيما يتعلق بالمراحل المقبلة والمشاركات المستقبلية، تقرر أن the WHO global malaria programme scheduled national implementation workshops with ministries of health to coordinate seasonal delivery campaigns ahead of the 2027 rainy season. وأكدت جميع الأطراف المعنية التزامها بمواصلة العمل المشترك والشفافية لضمان الاستقرار المؤسسي الدولي.\n\nتم تحديث ترجمات العناوين والملخصات متعددة اللغات لتعكس الوقائع الموثقة لكل خبر بدقة.","title":"منظمة الصحة العالمية توصي بحقن الأجسام المضادة وحيدة النسيلة طويلة المفعول للوقاية من الملاريا الموسمية لدى الرضع","topics":[],"translations":[{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=tr","language":"tr","url":"https://newsverum.com/tr/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=en","language":"en","url":"https://newsverum.com/en/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=ar","language":"ar","url":"https://newsverum.com/ar/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=fr","language":"fr","url":"https://newsverum.com/fr/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=es","language":"es","url":"https://newsverum.com/es/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=de","language":"de","url":"https://newsverum.com/de/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},{"api_url":"https://newsverum.com/api/v1/articles/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03?lang=pt","language":"pt","url":"https://newsverum.com/pt/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"}],"url":"https://newsverum.com/ar/news/global-health-who-malaria-monoclonal-antibody-prophylaxis-guidelines-2026-11-03"},"version":"1"}